QNTM · Quantum BioPharma Ltd
United States · RS rating 11 · As of 2026-11-03
| Price | 2.21 USD |
|---|---|
| 1-day change | -2.2% |
| RS rating (overall / 1M / 3M / 12M) | 11 / 10 / 27 / 9 |
| Stage | Declining |
| Composite / Minervini / CANSLIM score | 18 / 6 / 34 |
| Industry group (rank) | Medical-Biomed/Biotech (154) |
| EPS growth Q/Q | +84.6% |
| Sales growth Q/Q | – |
| Distance from 52-week high | +80.6% |
| Market cap (USD) | $19.0M |